Annuities

1 2 3 4 5 6 7 8   [27]

ETFs Beat Out Mutual Funds In Popularity, Study Shows

by

The popularity of ETFs has grown steadily and has finally passed mutual funds in financial advisors' recommendation, the FPA says.

Sen. Elizabeth Warren Targets Broker Annuity Perks To Build Support For Fiduciary Rule

by

She is contacting the U.S.’s 15 largest annuity providers asking for a list of all perks: car leases, NFL Super Bowl-style rings and other “kickbacks directed at annuity agents and brokers.”

How ‘Safe’ Investments Could Destroy Your Portfolio

by

After years of low interest rates and rising stock markets, once-conservative income strategies might actually be putting investors in risky situations.

Genworth Said To Seek Buyers For GLAIC Life, Annuity Unit

by

The move comes after the company lost about $1.6 billion in last year’s second half due to insufficient funds set aside to cover payouts on long-term care policies.

News From the Retirement Symposium: Panelists Tell Advisors They Can Be Crucial To Improving Retirement Security

by

Many Americans don't have enough money for the kind of retirement they would like, but advisors can use new strategies to help improve clients' later years, panelists said at FA's retirement...

The Long And Short Of It

by

Longevity annuities and QLAC get a lift from the Fed, but can that boost their numbers?

Northwestern Mutual To Pay $84M To Settle Annuities Lawsuit

by

Northwestern Mutual Life Insurance Co agreed to pay $84 million to settle claims it illegally reduced potential payouts on annuities it sold at least 30 years ago.

JPMorgan Joins Goldman As Indexed Annuities Boom Lures Banks

by

But the rising popularity of these vehicles caused one regulator to caution that some marketing materials may inflate investor expectations.

Sales Of Nursing Home Annuities Soar

by

Money that would have gone to a nursing home can be used to purchase an annuity that provides an income stream for the spouse remaining at home.

Paying For Gene Therapy: Are Annuities The Next Big Thing?

by

With growing resistance to the high price of cutting-edge treatments, some companies are working on a new payment model that rewards them for the long-term performance of their medicines.

1 2 3 4 5 6 7 8   [27]